These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
428 related items for PubMed ID: 16781485
1. Evidence-based management of polycythemia vera. Barbui T, Finazzi G. Best Pract Res Clin Haematol; 2006; 19(3):483-93. PubMed ID: 16781485 [Abstract] [Full Text] [Related]
3. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data. Finazzi G. Semin Thromb Hemost; 2006 Apr; 32(3):276-82. PubMed ID: 16673282 [Abstract] [Full Text] [Related]
4. Expertise-based management in essential thrombocythemia and polycythemia vera. Finazzi G, Barbui T. Cancer J; 2007 Apr; 13(6):372-6. PubMed ID: 18032974 [Abstract] [Full Text] [Related]
8. A contemporary approach to the diagnosis and management of polycythemia vera. Tefferi A. Curr Hematol Rep; 2003 May; 2(3):237-41. PubMed ID: 12901345 [Abstract] [Full Text] [Related]
9. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG. Michiels JJ, Barbui T, Finazzi G, Fuchtman SM, Kutti J, Rain JD, Silver RT, Tefferi A, Thiele J. Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896 [Abstract] [Full Text] [Related]
11. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G, Barbui T. J Clin Oncol; 2005 Apr 01; 23(10):2224-32. PubMed ID: 15710945 [Abstract] [Full Text] [Related]
12. Therapeutic options for essential thrombocythemia and polycythemia vera. Solberg LA. Semin Oncol; 2002 Jun 01; 29(3 Suppl 10):10-5. PubMed ID: 12096352 [Abstract] [Full Text] [Related]
13. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Semin Hematol; 1986 Apr 01; 23(2):132-43. PubMed ID: 3704665 [Abstract] [Full Text] [Related]
14. [Efficacious treatment of a fatal blood disease: polycythemia vera]. Sánchez Fayos J, Román Barbero A, Nevado Reviriego I. Sangre (Barc); 1997 Jun 01; 42(3):215-8. PubMed ID: 9381264 [No Abstract] [Full Text] [Related]
15. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD). Murphy S. Thromb Haemost; 1997 Jul 01; 78(1):622-6. PubMed ID: 9198227 [Abstract] [Full Text] [Related]
17. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party. Haematologica; 2008 Mar 01; 93(3):372-80. PubMed ID: 18268279 [Abstract] [Full Text] [Related]
18. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP). Finazzi G, low-dose aspirin in polycythemia (ECLAP). Pathol Biol (Paris); 2004 Jun 01; 52(5):285-8. PubMed ID: 15217715 [Abstract] [Full Text] [Related]
19. Treatment of polycythemia vera. Barbui T, Finazzi G. Haematologica; 1998 Feb 01; 83(2):143-9. PubMed ID: 9549926 [Abstract] [Full Text] [Related]
20. Modern treatment strategies in polycythemia vera. Gilbert HS. Semin Hematol; 2003 Jan 01; 40(1 Suppl 1):26-9. PubMed ID: 12682879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]